U.S. Food and Staples Retail Stock News

NYSE:DAN
NYSE:DANAuto Components

3 Stocks Estimated To Be Trading At Discounts Of Up To 44.1%

The United States market has shown robust performance, climbing 1.2% in the last week and rising 29% over the past year, with earnings projected to grow by 17% annually in the coming years. In such a thriving environment, identifying stocks that are trading below their intrinsic value can present attractive opportunities for investors seeking potential long-term gains.
NasdaqGS:BLLN
NasdaqGS:BLLNHealthcare

3 Promising Growth Companies With Insider Ownership Up To 27%

The United States market has experienced a robust performance, with a 1.2% increase over the last week and a substantial 29% rise over the past year, while earnings are anticipated to grow by 17% annually in the coming years. In this environment, growth companies with significant insider ownership can be particularly appealing as they often align management interests with shareholder value and may indicate confidence in the company's future prospects.
NYSEAM:LCTX
NYSEAM:LCTXBiotechs

Promising Penny Stocks To Consider In May 2026

The United States market has shown robust performance, with a 1.2% increase over the last week and a substantial 29% rise over the past year, alongside an optimistic forecast for earnings growth of 17% annually. In light of these conditions, investors might find opportunity in stocks that balance affordability with potential growth, particularly those often labeled as penny stocks. While the term may seem outdated, these smaller or newer companies can offer intriguing prospects when backed by...
NasdaqCM:PSIX
NasdaqCM:PSIXElectrical

US Undiscovered Gems to Explore This May 2026

The United States market has experienced a notable uptrend, climbing 1.2% in the last week and an impressive 29% over the past year, with earnings forecasted to grow by 17% annually. In this robust environment, identifying stocks that are not only poised for growth but also remain under the radar can offer unique opportunities for investors seeking to capitalize on these favorable conditions.
NasdaqGS:FHB
NasdaqGS:FHBBanks

Top Dividend Stocks To Consider In May 2026

The United States market has shown robust performance, rising 1.2% over the last week and 29% over the past year, with earnings projected to grow by 17% annually. In this dynamic environment, selecting dividend stocks that offer reliable income and potential for capital appreciation can be an effective strategy for investors looking to benefit from both current returns and future growth.
NYSE:GVA
NYSE:GVAConstruction

Granite Construction (GVA) Valuation Check After $600 Million Senior Notes Offering And Capital Structure Shift

Granite Construction (GVA) has come into focus after completing a $600 million senior notes offering due 2034. The move is tied to redeeming its 2028 convertible notes, settling conversions, and addressing other financing needs. See our latest analysis for Granite Construction. Recent trading has been firm, with the share price at $129.95 after a 1 day share price return of 1.82% and a year to date share price return of 9.51%. The 1 year total shareholder return of 42.80% and very large 3...
NYSE:AR
NYSE:AROil and Gas

A Look At Antero Resources (AR) Valuation After Recent Share Price Strength

Antero Resources (AR) has attracted investor attention after recent trading, with the stock closing at US$36.75. The move comes as investors weigh its latest share performance against its broader financial profile. See our latest analysis for Antero Resources. Recent trading softness, with a 7 day share price return of 5.72% and a 30 day share price return of 2.88%, sits against a 90 day share price gain of 6.8% and a 5 year total shareholder return of 173.23%. This suggests longer term...
NasdaqGM:CRSP
NasdaqGM:CRSPBiotechs

Why CRISPR Therapeutics (CRSP) Is Up 5.8% After Highlighting 2026 As a Defining Year

Earlier in May 2026, CRISPR Therapeutics reported Q1 results showing a smaller net loss, continued rollout of its approved gene-editing therapy Casgevy for sickle cell disease and beta-thalassemia, and progress across its broader pipeline. An important development is management’s characterization of 2026 as a “defining year,” with multiple expected clinical and commercial milestones supported by a US$2.40 billion cash position. We’ll now examine how the company’s narrowing losses and...
NYSE:ICE
NYSE:ICECapital Markets

A Look At Intercontinental Exchange (ICE) Valuation As New Crypto And GPU Futures Draw Investor Attention

Intercontinental Exchange (ICE) is drawing fresh investor attention after announcing new oil linked perpetual futures with crypto exchange OKX, along with plans with Ornn for GPU compute futures tied to the OCPI index. See our latest analysis for Intercontinental Exchange. The recent product announcements have arrived while the stock trades at US$152.97, with the share price down 3.5% over the past 30 days and total shareholder return declining 13.3% over the past year, despite a 52.2% gain...
NasdaqCM:XPEL
NasdaqCM:XPELAuto Components

A Look At XPEL (XPEL) Valuation As Shares Show Mixed Recent Performance

Recent share performance and business snapshot XPEL (XPEL) has seen mixed share performance, with the stock up 2.2% over the past day and 3.4% over the past week, but down over the past month, past 3 months, and year to date. The company reports annual revenue of US$489.7m and net income of US$53.0m, with annual revenue growth of 11.3% and net income growth of 28.0%, reflecting its position in automotive protective films, coatings, and related services. See our latest analysis for XPEL. At a...
NYSE:ITW
NYSE:ITWMachinery

Assessing Illinois Tool Works (ITW) Valuation As Analyst Targets Clash With Cash Flow Estimates

Stock performance snapshot Illinois Tool Works (ITW) has seen mixed share performance recently, with the stock up 0.9% over the past day and 2.0% over the past week, but down 6.3% over the past month. Over the past 3 months, the stock is down 13.0%, while the year to date return is 1.1%. Over longer periods, the total return stands at 4.8% over the past year, 21.1% over 3 years, and 21.6% over 5 years. See our latest analysis for Illinois Tool Works. With the share price at $252.20, recent...
NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

Assessing Amgen (AMGN) Valuation After Japan Safety Concerns Over Rare Disease Drug

A Wall Street Journal report that linked at least 20 deaths and 22 serious liver injuries in Japan to an Amgen (AMGN) rare disease drug has quickly put fresh attention on the stock. See our latest analysis for Amgen. The latest safety headlines arrive after a mixed stretch for the stock, with a 1 day share price return of 0.56%, a 7 day share price return of 2.58%, and a 90 day share price return down 11.72% from recent highs. At the same time, the 1 year total shareholder return of 25.07%...
NYSE:VLTO
NYSE:VLTOCommercial Services

Is Veralto (VLTO) Offering Value After Its Post Spin Off Share Price Slide

If you are wondering whether Veralto stock is priced attractively right now or if the recent share moves are a warning sign, this article explains what the current valuation may imply for you as an investor. Veralto shares last closed at US$86.80, with the stock edging up 0.4% over the past week, easing back by 2.1% over the last month, and declining 11.9% year to date and 14.1% over the past year. Recent coverage has focused on Veralto as an independent player in the commercial services...
NYSE:BNY
NYSE:BNYCapital Markets

A Look At Bank Of New York Mellon Corporation’s Valuation After Strong Q1 Earnings And Snapdocs Partnership

Bank of New York Mellon Corporation (BNY) is drawing fresh attention after reporting Q1 revenue growth of 13.8% and topping analyst expectations by 4.3%, alongside a new digital mortgage collateral partnership with Snapdocs. See our latest analysis for Bank of New York Mellon. Those Q1 numbers and the Snapdocs tie up have arrived alongside firm price momentum, with the share price at $139.15 and a 1 year total shareholder return of 57.12%, building on very strong multi year gains. If you are...